Tuis600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Vorige sluiting
¥3,72
Dagwisseling
¥3,67 - ¥3,75
Jaarwisseling
¥3,06 - ¥4,97
Markkapitalisasie
9,17 mjd CNY
Gemiddelde volume
41,59 m
P/V-verhouding
20,80
Dividend-opbrengs
-
Primêre beurs
SHA
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 3,90 mjd | -5,29% |
Bedryfskoste | 838,57 m | 2,13% |
Netto inkomste | 68,89 m | -58,22% |
Netto winsgrens | 1,77 | -55,86% |
Wins per aandeel | — | — |
EBITDA | 166,37 m | -50,19% |
Effektiewe belastingkoers | 34,67% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,74 mjd | -12,32% |
Totale bates | 14,08 mjd | -1,31% |
Totale aanspreeklikheid | 7,67 mjd | -7,75% |
Totale ekwiteit | 6,41 mjd | — |
Uitstaande aandele | 2,52 mjd | — |
Prys om te bespreek | 1,65 | — |
Opbrengs op bates | 2,00% | — |
Opbrengs op kapitaal | 3,67% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 68,89 m | -58,22% |
Kontant van bedrywe | -192,48 m | -283,26% |
Kontant van beleggings | -54,77 m | -55,00% |
Kontant van finansiering | -88,11 m | 49,20% |
Netto kontantverandering | -334,93 m | -222,01% |
Beskikbare kontantvloei | -402,50 m | -471,06% |
Meer oor
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Gestig
1988
Webwerf
Werknemers
10 180
